Don Tracy, Associate Editor

UCB executive speaks on recent FDA approval of Bimzelx.

National Library of Medicine study emphasizes inadequacies in ensuring the safety and efficacy of over-the-counter dietary supplements.

An overview of the nine biggest developments to expect across the healthcare industry in the year ahead.

JAMA study evaluates differences in coverage types and potential from 2016-2021.

Findings show that a considerable number of adults remain uneducated on how herpes zoster is triggered.

Blenrep significantly extended the time to disease progression or death against existing care methods as a second-line treatment for relapsed or refractory multiple myeloma.